CLX vs KMB: Clorox and Kimberly-Clark compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- Kimberly-Clark is the larger company, worth $32.2B, about 3.3 times Clorox.
- Kimberly-Clark grew revenue faster over the last year (+0.6% vs +0.1%).
- On earnings, Clorox is the cheaper stock (13.1x vs 18.8x).
- Kimberly-Clark's price assumes faster free cash flow growth: about 5% a year, against -1% for Clorox (reverse DCF).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | CLX | KMB |
|---|---|---|
| Market cap | $9.8B | $32.2B |
| Share price | $82.21 | $97.59 |
| Revenue (last fiscal year) | $7.1B | $16.4B |
| Free cash flow (last fiscal year) | $761M | $1.6B |
| Revenue growth, last year | +0.1% | +0.6% |
| Revenue growth per year, last 5 fiscal years | -0.8% | -4.1% |
| Operating margin | — | 15.2% |
| Net margin | 11.2% | 11.8% |
| Return on equity | — | 111.7% |
| P/E (trailing) | 13.1x | 18.8x |
| Price / free cash flow | 12.8x | 19.7x |
| EV / EBITDA | 10.1x | 12.3x |
| FCF growth the price implies | -0.83% | 4.8% |
| Dividend yield | 6.1% | 5.2% |
| Debt / equity | — | 9.53x |
| Fundamental grade | C | D |
| Superinvestors holding it | 4 | 8 |
| Insider purchases, last 12 months | 5 | 8 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Clorox
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $7.3B | $945M | — |
| 2022 | $7.1B | $535M | — |
| 2023 | $7.4B | $930M | — |
| 2024 | $7.1B | $483M | — |
| 2025 | $7.1B | $761M | — |
Kimberly-Clark
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $19.4B | $1.7B | 13.2% |
| 2022 | $20.2B | $1.9B | 13.3% |
| 2023 | $17.1B | $2.8B | 11.2% |
| 2024 | $16.8B | $2.5B | 16.1% |
| 2025 | $16.4B | $1.6B | 14.3% |
Where the revenue comes from
Clorox · by segments, 2026
Health and Wellness$2.7B40%
Household$1.8B27%
Lifestyle$1.1B17%
International$1.1B17%
Kimberly-Clark · by segments, 2025
NA$10.8B65%
IPC$5.7B35%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CLX in InvestinglyQuestions
Which is bigger, Clorox or Kimberly-Clark?
Kimberly-Clark (KMB), at $32.2B against $9.8B.
Is CLX or KMB cheaper?
By trailing P/E, Clorox (13.1x) is cheaper than Kimberly-Clark (18.8x). A lower multiple can also mean the market expects less growth.
Which grows faster, CLX or KMB?
Kimberly-Clark: revenue grew +0.6% over the last year, against +0.1%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.